Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth A Raetz

Showing results (101-110 of 155) with videos related to

Pageof 16
Sort By:
Blood Advances|August 15, 2025
Role of race and ethnicity in survival among children/young adults with relapsed ALL: a Children's Oncology Group reportJohn A Ligon, Lingyun Ji, Alice Dang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2026
Erratum: Successful Outcomes of Newly Diagnosed T Lymphoblastic Lymphoma: Results From Children's Oncology Group AALL0434Robert J Hayashi, Stuart S Winter, Kimberly P Dunsmore, et al.
Blood|January 5, 2023
Central nervous system status is prognostic in T-cell acute lymphoblastic leukemia: a Children's Oncology Group reportNathan P Gossai, Meenakshi Devidas, Zhiguo Chen, et al.
Blood Advances|May 5, 2026
Toxicity from asparaginase during acute lymphoblastic leukemia induction: A report from the Children's Oncology GroupEtan Orgel, Luke D Maese, Meenakshi Devidas, et al.
Cancer|February 24, 2022
Sex-based disparities in outcome in pediatric acute lymphoblastic leukemia: a Children's Oncology Group reportSumit Gupta, David T Teachey, Zhiguo Chen, et al.
Blood|May 20, 2015
Genome-wide analysis links NFATC2 with asparaginase hypersensitivityChristian A Fernandez, Colton Smith, Wenjian Yang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2014
Pharmacokinetic and pharmacodynamic properties of calaspargase pegol Escherichia coli L-asparaginase in the treatment of patients with acute lymphoblastic leukemia: results from Children's Oncology Group Study AALL07P4Anne L Angiolillo, Reuven J Schore, Meenakshi Devidas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 5, 2020
Impact of Intrathecal Triple Therapy Versus Intrathecal Methotrexate on Disease-Free Survival for High-Risk B-Lymphoblastic Leukemia: Children's Oncology Group Study AALL1131Wanda L Salzer, Michael J Burke, Meenakshi Devidas, et al.
Blood|November 22, 2015
Genetic risk factors for the development of osteonecrosis in children under age 10 treated for acute lymphoblastic leukemiaSeth E Karol, Leonard A Mattano, Wenjian Yang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2016
Dexamethasone and High-Dose Methotrexate Improve Outcome for Children and Young Adults With High-Risk B-Acute Lymphoblastic Leukemia: A Report From Children's Oncology Group Study AALL0232Eric C Larsen, Meenakshi Devidas, Si Chen, et al.
Pageof 16

Showing results (101-110 of 155) with videos related to

Sort By:
Pageof 16
Blood Advances|August 15, 2025
Role of race and ethnicity in survival among children/young adults with relapsed ALL: a Children's Oncology Group reportJohn A Ligon, Lingyun Ji, Alice Dang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2026
Erratum: Successful Outcomes of Newly Diagnosed T Lymphoblastic Lymphoma: Results From Children's Oncology Group AALL0434Robert J Hayashi, Stuart S Winter, Kimberly P Dunsmore, et al.
Blood|January 5, 2023
Central nervous system status is prognostic in T-cell acute lymphoblastic leukemia: a Children's Oncology Group reportNathan P Gossai, Meenakshi Devidas, Zhiguo Chen, et al.
Blood Advances|May 5, 2026
Toxicity from asparaginase during acute lymphoblastic leukemia induction: A report from the Children's Oncology GroupEtan Orgel, Luke D Maese, Meenakshi Devidas, et al.
Cancer|February 24, 2022
Sex-based disparities in outcome in pediatric acute lymphoblastic leukemia: a Children's Oncology Group reportSumit Gupta, David T Teachey, Zhiguo Chen, et al.
Blood|May 20, 2015
Genome-wide analysis links NFATC2 with asparaginase hypersensitivityChristian A Fernandez, Colton Smith, Wenjian Yang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2014
Pharmacokinetic and pharmacodynamic properties of calaspargase pegol Escherichia coli L-asparaginase in the treatment of patients with acute lymphoblastic leukemia: results from Children's Oncology Group Study AALL07P4Anne L Angiolillo, Reuven J Schore, Meenakshi Devidas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 5, 2020
Impact of Intrathecal Triple Therapy Versus Intrathecal Methotrexate on Disease-Free Survival for High-Risk B-Lymphoblastic Leukemia: Children's Oncology Group Study AALL1131Wanda L Salzer, Michael J Burke, Meenakshi Devidas, et al.
Blood|November 22, 2015
Genetic risk factors for the development of osteonecrosis in children under age 10 treated for acute lymphoblastic leukemiaSeth E Karol, Leonard A Mattano, Wenjian Yang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2016
Dexamethasone and High-Dose Methotrexate Improve Outcome for Children and Young Adults With High-Risk B-Acute Lymphoblastic Leukemia: A Report From Children's Oncology Group Study AALL0232Eric C Larsen, Meenakshi Devidas, Si Chen, et al.
Pageof 16